Scarica l'app Stockscreener
1.21
1.63%
-0.02
Dopo l'orario di chiusura:
1.24
0.03
+2.48%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$1.23
Aprire:
$1.2235
Volume 24 ore:
45,586
Relative Volume:
0.48
Capitalizzazione di mercato:
$9.12M
Reddito:
-
Utile/perdita netta:
$-25.56M
Rapporto P/E:
-0.2327
EPS:
-5.2
Flusso di cassa netto:
$-19.35M
1 W Prestazione:
-0.82%
1M Prestazione:
+0.00%
6M Prestazione:
-83.82%
1 anno Prestazione:
-32.02%
Intervallo 1D:
$1.20
$1.25
Intervallo di 1 settimana:
$1.16
$1.30
Portata 52W:
$0.62
$9.56
Biovie Inc Stock (BIVI) Company Profile
Nome
Biovie Inc
Settore
Industria
Telefono
775-888-3162
Indirizzo
680 W NYE LANE, CARSON CITY
Confronta BIVI con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
BIVI
Biovie Inc
|
1.21 | 9.27M | 0 | -25.56M | -19.35M | -5.20 |
|
VRTX
Vertex Pharmaceuticals Inc
|
474.17 | 120.98B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
771.25 | 80.15B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ARGX
Argen X Se Adr
|
864.42 | 51.56B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
354.75 | 47.74B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ONC
Beone Medicines Ltd Adr
|
336.16 | 37.38B | 4.98B | 69.59M | 525.67M | 0.5197 |
Biovie Inc Stock (BIVI) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2022-07-22 | Iniziato | Cantor Fitzgerald | Overweight |
| 2021-01-15 | Iniziato | B. Riley Securities | Buy |
Biovie Inc Borsa (BIVI) Ultime notizie
Exit Recap: Will BioVie Inc stock go up in YEAR2025 Key Lessons & Stepwise Entry/Exit Trade Alerts - baoquankhu1.vn
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors of an Investigation Involving Possible Securities Fraud Violations by Officers of BioVie Inc. (BIVI) - ACCESS Newswire
New to The Street Broadcasts Show #716 Tonight at 6:30 PM ET on Bloomberg Television Featuring Stardust Power (NASDAQ:SDST), BioVie (NASDAQ:BIVI), Roadzen (NASDAQ:RDZN), with Special Segments from Kelsey Grammer on KAREN and Andrew - courier-journal.com
Can BioVie Inc. stock sustain free cash flow growthJuly 2025 Highlights & Target Return Focused Picks - bollywoodhelpline.com
Short Covering: Will BioVie Inc outperform the market in YEARWeekly Trade Summary & Daily Momentum Trading Reports - baoquankhu1.vn
BioVie hits enrolment milestone in early Parkinson’s trial, data due later this year - Proactive financial news
BioVie (NASDAQ:BIVI) Stock Price Down 4.7% – Should You Sell? - Defense World
BioVie | 4: Statement of changes in beneficial ownership of securities-Officer Palumbo Joseph M - 富途牛牛
BioVie completes enrollment for Parkinson’s drug trial By Investing.com - Investing.com Nigeria
Is Biovie's SUNRISE-PD The First Light Of Change In Early Parkinson's? - RTTNews
Why BioVie Inc. stock is rated strong buyJuly 2025 Short Interest & Fast Moving Trade Plans - Улправда
Will BioVie Inc. stock benefit from infrastructure spendingWeekly Profit Summary & Technical Pattern Based Buy Signals - ulpravda.ru
Is BioVie Inc. stock cheap compared to fundamentalsJuly 2025 Outlook & Safe Entry Point Identification - Улправда
Why retail investors pile into BioVie Inc. stockQuarterly Profit Review & Safe Capital Investment Plans - Улправда
Will BioVie Inc. stock see insider buyingMarket Activity Report & Expert Approved Momentum Ideas - ulpravda.ru
Stock Analysis: How supply chain issues affect BioVie Inc. stockNew Guidance & Fast Exit Strategy with Risk Control - Улправда
BioVie completes enrollment for Parkinson’s drug trial - Investing.com
BioVie Completes Enrollment in Phase 2 SUNRISE-PD Trial in Early Parkinson’s Disease - GlobeNewswire
Is BioVie Inc. stock dividend yield sustainableSmall Cap Stock Opportunities & Affordable Market Insights - Улправда
Nexalin Technology and BioVie Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV - sctimes.com
Aug Shorts: Why BioVie Inc stock is rated strong buyWeekly Stock Analysis & High Accuracy Trade Signal Alerts - moha.gov.vn
HALPER SADEH LLC ENCOURAGES BIOVIE INC. SHAREHOLDERS TO CONTACT THE FIRM TO DISCUSS THEIR RIGHTS - The Malaysian Reserve
BioVie (NASDAQ:BIVI) Trading Down 5.8% – What’s Next? - Defense World
BioVie Inc Stock Analysis and ForecastEconomic Impact on Stocks & Free Real-Time Stock Market Data - earlytimes.in
Will BioVie Inc. stock outperform Dow Jones indexJuly 2025 Snapshot & Fast Gain Stock Trading Tips - ulpravda.ru
BioVie advances lead drug candidatesICYMI - Proactive financial news
Breakout Zone: Will BioVie Inc. stock outperform Dow Jones indexJobs Report & Reliable Price Breakout Alerts - Улправда
What Wall Street predicts for BioVie Inc. stock priceMarket Performance Summary & Stepwise Swing Trade Plans - Улправда
Aug Movers: How BioVie Inc. stock compares to industry benchmarksJuly 2025 Drop Watch & High Accuracy Swing Entry Alerts - Улправда
How BioVie Inc. stock compares to industry benchmarks2025 EndofYear Setup & Precise Buy Zone Identification - ulpravda.ru
Fund Flows: What momentum indicators show for BioVie Inc. stockJuly 2025 Outlook & Daily Chart Pattern Signal Reports - Улправда
What momentum indicators show for BioVie Inc. stockQuarterly Performance Summary & Technical Confirmation Trade Alerts - Улправда
BioVie advances Parkinson’s, long COVID, and liver disease programs ahead of 2026 - Proactive financial news
What makes BioVie (BIVI) a new buy stock - MSN
What Makes BioVie (BIVI) a New Buy Stock - sharewise.com
BioVie Inc. (BIVI) Discusses Clinical Progress of Lead Drug Candidates Targeting Parkinson's, Alzheimer's, and Liver DiseaseSlideshow (NASDAQ:BIVI) 2025-12-09 - Seeking Alpha
New to The Street Broadcasts Tonight on Bloomberg at 6:30 PM EST Featuring Roadzen, BioVie, and TY J Young Wealth - The Florida Times-Union
Breakout Watch: How BioVie Inc. stock compares to industry benchmarksPortfolio Performance Summary & Safe Capital Growth Trade Ideas - BỘ NỘI VỤ
Can BioVie Inc. stock sustain institutional interestJuly 2025 Review & Low Drawdown Trading Strategies - Newser
BioVie Inc. (BIVI) -5.7% in After-hours: Stock Declines Amid Routine Trading Conditions - Stocks Telegraph
BioVie (NASDAQ:BIVI) Shares Up 0.3% – Here’s What Happened - Defense World
BIVI SEC FilingsBiovie Inc 10-K, 10-Q, 8-K Forms - Stock Titan
[S-8] BIOVIE INC. Employee Benefit Plan Registration | BIVI SEC FilingForm S-8 - Stock Titan
Biovie Inc Azioni (BIVI) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
2.09%
0.48%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):